🔗 Permalink

Assignee profile:

PATRYS LIMITED

City:

Melbourne

Country:

Australia

Published Applications:

Last publication date:

2015-03-12

Patent Grants:

Last grant date:

2017-10-10

Top Inventors for applications by PATRYS LIMITED

These are the the leading inventors for applications assigned to PATRYS LIMITED:

HEINZ PETER VOLLMERS 11 Wurzburg, Germany
Frank Hensel 5 Wurzburg, Germany
Hans Konrad Mueller-Hermelink 5 Wurzburg, Germany
Leodevico L. Ilag 4 Balwyn, Australia

HEINZ VOLLMERS 4 Wurzburg, Germany
Lishanthi Udabage 3 Rowville, Australia
Stephanie Ute Brandlein 3 Zellingen, Germany
Arndt-Rene Kelter 3 Alfter, Germany

Barbara Power 3 Blackburn, Australia
Frank Schoenen 2 Wurzburg, Germany
Andreas Thalheimer 2 Wurzburg, Germany
Barbara E. Power 2 Blackburn, Australia

Christopher Garth Hosking 2 Nunawading, Australia
Bertram Illert 1 Wurzburg, Germany
Stephanie ute Brandlein 1 Zelllingen, Germany
Leodevico I. Ilag 1 Balwyn, Australia

Christopher Garth Hosking 1 Mount Waverley, Australia
Vic Ilag 1 Balwyn, Australia
Hans-Konrad Müller-Hermelink 1 Wurzburg, Germany

Recent patent applications by PATRYS LIMITED

PATRYS LIMITED based in Melbourne, AU has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2015-03-12 ✅ Patent 9,783,599 granted on 2017-10-10

US20150071931A1

Chemistry; metallurgy

LM-antibodies, functional fragments, LM-1 target antigen, and methods for making and using same

#2 | 2014-10-09 ✅ Patent 9,265,817 granted on 2016-02-23

US20140302074A1

Human necessities

PAT-LM1 epitopes and methods for using same

#3 | 2013-04-25

US20130101588A1

Chemistry; metallurgy

NOVEL GLYCOSYLATED PEPTIDE TARGET IN NEOPLASTIC CELLS

#4 | 2013-03-21 ✅ Patent 9,273,125 granted on 2016-03-01

US20130072664A1

Chemistry; metallurgy

Human monoclonal antibody having fat-reducing effect

#5 | 2013-02-14 ✅ Patent 8,741,296 granted on 2014-06-03

US20130039849A1

Chemistry; metallurgy

Adenocarcinoma specific antibody SAM-6, and uses thereof

#6 | 2011-11-24 ✅ Patent 8,562,995 granted on 2013-10-22

US20110287021A1

Chemistry; metallurgy

Neoplasm specific antibodies and uses thereof

#7 | 2011-08-25

US20110207917A1

Chemistry; metallurgy

SAM-6 VARIANTS, TARGET AND METHODS OF USE

#8 | 2011-03-31

US20110076763A1

Physics

NEOPLASM SPECIFIC ANTIBODIES AND USES THEREOF

#9 | 2010-12-23

US20100322936A1

Chemistry; metallurgy

LM-1 ANTIBODIES, FUNCTIONAL FRAGMENTS, LM-1 TARGET ANTIGEN, AND METHODS FOR MAKING AND USING SAME

#10 | 2010-12-16

US20100317826A1

Chemistry; metallurgy

NEOPLASM SPECIFIC ANTIBODIES AND USES THEREOF

#11 | 2009-11-26

US20090291083A1

Chemistry; metallurgy

BARB4 TARGET, ANTIBODY DESIGNATED BARB4, BARB4 RELATED ANTIBODIES, AND METHODS OF MAKING AND USING SAME

#12 | 2009-10-15

US20090258020A1

Chemistry; metallurgy

ANTIBODY DESIGNATED BARB3, BARB3 RELATED ANTIBODIES, AND METHODS OF MAKING AND USING SAME

#13 | 2009-08-13

US20090202570A1

Chemistry; metallurgy

PM-2 ANTIBODIES, FUNCTIONAL FRAGMENTS AND METHODS FOR TREATING METASTASIS

#14 | 2008-08-21

US20080199475A1

Chemistry; metallurgy

NOVEL GLYCOSYLATED PEPTIDE TARGET IN NEOPLASTIC CELLS

#15 | 2008-01-24 ✅ Patent 7,741,444 granted on 2010-06-22

US20080020457A1

Chemistry; metallurgy

Neoplasm specific antibodies and uses thereof

AssigneeID:

9263 ⎘